These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28459463)

  • 1. MYCN induces neuroblastoma in primary neural crest cells.
    Olsen RR; Otero JH; García-López J; Wallace K; Finkelstein D; Rehg JE; Yin Z; Wang YD; Freeman KW
    Oncogene; 2017 Aug; 36(35):5075-5082. PubMed ID: 28459463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.
    Yi JS; Sias-Garcia O; Nasholm N; Hu X; Iniguez AB; Hall MD; Davis M; Guha R; Moreno-Smith M; Barbieri E; Duong K; Koach J; Qi J; Bradner JE; Stegmaier K; Weiss WA; Gustafson WC
    Neoplasia; 2021 Jun; 23(6):624-633. PubMed ID: 34107377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations.
    Saldana-Guerrero IM; Montano-Gutierrez LF; Boswell K; Hafemeister C; Poon E; Shaw LE; Stavish D; Lea RA; Wernig-Zorc S; Bozsaky E; Fetahu IS; Zoescher P; Pötschger U; Bernkopf M; Wenninger-Weinzierl A; Sturtzel C; Souilhol C; Tarelli S; Shoeb MR; Bozatzi P; Rados M; Guarini M; Buri MC; Weninger W; Putz EM; Huang M; Ladenstein R; Andrews PW; Barbaric I; Cresswell GD; Bryant HE; Distel M; Chesler L; Taschner-Mandl S; Farlik M; Tsakiridis A; Halbritter F
    Nat Commun; 2024 May; 15(1):3745. PubMed ID: 38702304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations.
    Dabkowski TR; Varkhedi M; Song JJ; Gozlan EC; Blanck G
    JCO Precis Oncol; 2023 Sep; 7():e2300057. PubMed ID: 38085056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis.
    Oskouian B; Lee JY; Asgharzadeh S; Khan R; Zhang M; Weisbrod JR; Choi YJ; Puri L; Aguilar AE; Zhao P; Saba JD
    Oncogene; 2024 Apr; 43(16):1203-1213. PubMed ID: 38413795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity.
    Yang Y; Wang S; Cai J; Liang J; Zhang Y; Xie Y; Luo F; Tang J; Gao Y; Shen S; Feng H; Li Y
    Cell Oncol (Dordr); 2023 Feb; 46(1):133-143. PubMed ID: 36520365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroblastoma progress on many fronts: the Neuroblastoma Research Symposium.
    Wylie L; Philpott A
    Pediatr Blood Cancer; 2012 Apr; 58(4):649-51. PubMed ID: 21922652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.
    Teitz T; Inoue M; Valentine MB; Zhu K; Rehg JE; Zhao W; Finkelstein D; Wang YD; Johnson MD; Calabrese C; Rubinstein M; Hakem R; Weiss WA; Lahti JM
    Cancer Res; 2013 Jul; 73(13):4086-97. PubMed ID: 23536557
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Fredlund E; Andersson S; Hilgert E; Monferrer E; Álvarez-Hernán G; Karakaya S; Loontiens S; Bek JW; Gregor T; Lecomte E; Magnusson E; Miltenyte E; Cabirol M; Kyknas M; Engström N; Henriksson MA; Hammarlund E; Rosenblum JS; Noguera R; Speleman F; van Nes J; Mohlin S
    Sci Adv; 2024 Jun; 10(25):eado1583. PubMed ID: 38905335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma.
    Dvorkina M; Nieddu V; Chakelam S; Pezzolo A; Cantilena S; Leite AP; Chayka O; Regad T; Pistorio A; Sementa AR; Virasami A; Barton J; Montano X; Lechertier T; Brindle N; Morgenstern D; Lebras M; Burns AJ; Saunders NJ; Hodivala-Dilke K; Bagella L; De The H; Anderson J; Sebire N; Pistoia V; Sala A; Salomoni P
    Clin Cancer Res; 2016 Jul; 22(13):3398-409. PubMed ID: 27076624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic structural variation targets neurodevelopmental genes and identifies
    Lopez G; Conkrite KL; Doepner M; Rathi KS; Modi A; Vaksman Z; Farra LM; Hyson E; Noureddine M; Wei JS; Smith MA; Asgharzadeh S; Seeger RC; Khan J; Auvil JG; Gerhard DS; Maris JM; Diskin SJ
    Genome Res; 2020 Sep; 30(9):1228-1242. PubMed ID: 32796005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma Patients' Outcome and Chromosomal Instability.
    Ognibene M; De Marco P; Amoroso L; Fragola M; Zara F; Parodi S; Pezzolo A
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.
    Schoof M; Godbole S; Albert TK; Dottermusch M; Walter C; Ballast A; Qin N; Olivera MB; Göbel C; Neyazi S; Holdhof D; Kresbach C; Peter LS; Epplen GD; Thaden V; Spohn M; Blattner-Johnson M; Modemann F; Mynarek M; Rutkowski S; Sill M; Varghese J; Afflerbach AK; Eckhardt A; Münter D; Verma A; Struve N; Jones DTW; Remke M; Neumann JE; Kerl K; Schüller U
    Nat Commun; 2023 Nov; 14(1):7717. PubMed ID: 38001143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells.
    Zanotti S; Vanhauwaert S; Van Neste C; Olexiouk V; Van Laere J; Verschuuren M; Van der Meulen J; Mus LM; Durinck K; Tilleman L; Deforce D; Van Nieuwerburgh F; Hogarty MD; Decaesteker B; De Vos WH; Speleman F
    Sci Rep; 2021 Jul; 11(1):14454. PubMed ID: 34262099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma.
    Becker J; Wilting J
    Cell Mol Life Sci; 2018 Mar; 75(6):1057-1070. PubMed ID: 29058015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Id2 Protein in Neuroblatoma in Children.
    Wieczorek A; Balwierz W
    Pathol Oncol Res; 2015 Sep; 21(4):999-1004. PubMed ID: 25771836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of stem cells from human neuroblastoma cell lines and in tumors.
    Walton JD; Kattan DR; Thomas SK; Spengler BA; Guo HF; Biedler JL; Cheung NK; Ross RA
    Neoplasia; 2004; 6(6):838-45. PubMed ID: 15720811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell atlas of developing murine adrenal gland reveals relation of Schwann cell precursor signature to neuroblastoma phenotype.
    Hanemaaijer ES; Margaritis T; Sanders K; Bos FL; Candelli T; Al-Saati H; van Noesel MM; Meyer-Wentrup FAG; van de Wetering M; Holstege FCP; Clevers H
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33500353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroblastoma-like schwannoma of the lung: report of a case].
    Hua HJ; Li KD; Zhu Y; Fan QH; Li H
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):492-494. PubMed ID: 38678334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial Response to Naxitamab for Brain Metastasis in Neuroblastoma.
    Onyeukwu C; Williams A; Seyboth B; Muñoz L; Scaria G; Kent P
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e188-e190. PubMed ID: 38189408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.